Article Versions Notes

Furumoto H, Okada R, Kato T, Wakiyama H, Inagaki F, Fukushima H, Okuyama S, Furusawa A, Choyke PL, Kobayashi H. Optimal Light Dose for hEGFR-Targeted Near-Infrared Photoimmunotherapy. Cancers. 2022; 14(16):4042. https://doi.org/10.3390/cancers14164042

Furumoto, Hideyuki, Ryuhei Okada, Takuya Kato, Hiroaki Wakiyama, Fuyuki Inagaki, Hiroshi Fukushima, Shuhei Okuyama, Aki Furusawa, Peter L. Choyke, and Hisataka Kobayashi. 2022. "Optimal Light Dose for hEGFR-Targeted Near-Infrared Photoimmunotherapy" Cancers 14, no. 16: 4042. https://doi.org/10.3390/cancers14164042

Furumoto, H., Okada, R., Kato, T., Wakiyama, H., Inagaki, F., Fukushima, H., Okuyama, S., Furusawa, A., Choyke, P. L., & Kobayashi, H. (2022). Optimal Light Dose for hEGFR-Targeted Near-Infrared Photoimmunotherapy. Cancers, 14(16), 4042. https://doi.org/10.3390/cancers14164042